*T max shown as median (range). More than two-thirds of women experience hot flashes during menopause, and approximately 25% of women during perimenopause and in the first years after menopause ...

A new investigational delivery method for localized vaginal estrogen therapy that utilizes an applicator free softgel to alleviate moderate-to-severe vaginal pain during intercourse (dyspareunia), a ...

The FDA approval was supported by findings from a Phase 3, randomized, double-blind, placebo-controlled study that evaluated Imvexxy (4mcg and 10mcg) vs placebo from baseline to week 12. The Food and ...

According to the Imvexxy prescribing information, women should generally be started at the 4mcg dosage strength with dosage adjustment guided by clinical response. Imvexxy (estradiol vaginal inserts) ...